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Risk of developing Alzheimer’s disease is increased by older age, genetic factors, and several medical risk
factors. Studies have also suggested that dietary and lifestyle factors may inﬂuence risk, raising the
possibility that preventive strategies may be effective. This body of research is incomplete. However,
because the most scientiﬁcally supported lifestyle factors for Alzheimer’s disease are known factors for
cardiovascular diseases and diabetes, it is reasonable to provide preliminary guidance to help individuals
who wish to reduce their risk. At the International Conference on Nutrition and the Brain, Washington,
DC, July 19e20, 2013, speakers were asked to comment on possible guidelines for Alzheimer’s disease
prevention, with an aim of developing a set of practical, albeit preliminary, steps to be recommended to
members of the public. From this discussion, 7 guidelines emerged related to healthful diet and exercise
habits.
 2014 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Alzheimer’s disease affected an estimated 4.7 million Americans
in 2010, and its prevalence is expected to nearly triple in comingdicine, George Washington
, Suite 400, Washington, DC
403.
).
Family Medicine, University
frica.
Y-NC-ND license.decades (Hebert et al., 2013). Several factors contribute to the risk of
developing late-onset Alzheimer’s disease, including older age,
genetic factors (especially the presence of the APOEε4 allele), family
history, a history of head trauma, midlife hypertension, obesity,
diabetes, and hypercholesterolemia (Bendlin et al., 2010).
In addition, recent prospective studies have shown that certain
dietary and lifestyle factors, including saturated fat intake, vitamin
E intake, and physical exercise, among others, are associated with
Alzheimer’s risk, suggesting that prevention strategies may be
applicable for these factors. In each of these areas, scientiﬁc evi-
dence is less than complete. Nonetheless, individuals at risk for
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a daily basis and need to act on the best evidence available to
them, even when scientiﬁc consensus may not have been
achieved.
In toxicology, the “precautionary principle” is invoked in situ-
ations in which there is a substantial basis for concern regarding
the health consequences of an exposure and for which available
data preclude a comprehensive evaluation of risk (European
Commission, 2000). A similar approach can be applied to nutri-
tional and other lifestyle-related exposures, particularly for con-
ditions, such as cancer or Alzheimer’s disease, for which there may
be a long latency period between exposure and disease manifes-
tation and for which randomized controlled trials are impractical
or are, for whatever reason, not rapidly forthcoming. Some have
argued that the level of evidence required for making dietary
recommendations for disease prevention may be different from
that required for establishing the efﬁcacy of medical treatments,
such as pharmaceuticals (Blumberg et al., 2010).
At the International Conference on Nutrition and the Brain,
Washington, DC, July 19e20, 2013, evidence regarding the in-
ﬂuence of dietary factors, physical and mental exercise, and sleep
on aspects of cognition was reviewed, and conference speakers
were asked to comment on possible dietary and lifestyle guide-
lines for Alzheimer’s disease prevention, with an aim of devel-
oping a set of practical steps to be recommended to members of
the public.2. Methods
The following principles were applied to the development of
guidelines:
1. Guidelines were to be based on substantial, although not
necessarily conclusive, evidence of beneﬁt.
2. Implementation of guidelines should present no reasonable
risk of harm.
3. The guidelines were to be considered to be subject to modiﬁ-
cation as scientiﬁc evidence evolves.3. Results
Seven guidelines emerged and are as follows:
1. Minimize your intake of saturated fats and trans fats. Saturated
fat is found primarily in dairy products, meats, and certain oils
(coconut and palm oils). Trans fats are found in many snack
pastries and fried foods and are listed on labels as “partially
hydrogenated oils.”
2. Vegetables, legumes (beans, peas, and lentils), fruits, and whole
grains should replace meats and dairy products as primary
staples of the diet.
3. Vitamin E should come from foods, rather than supplements.
Healthful food sources of vitamin E include seeds, nuts, green
leafy vegetables, and whole grains. The recommended dietary
allowance (RDA) for vitamin E is 15 mg per day.
4. A reliable source of vitamin B12, such as fortiﬁed foods or a
supplement providing at least the recommended daily allow-
ance (2.4 mg per day for adults), should be part of your daily
diet. Have your blood levels of vitamin B12 checked regularly as
many factors, including age, may impair absorption.
5. If using multiple vitamins, choose those without iron and
copper and consume iron supplements only when directed by
your physician.6. Although aluminum’s role in Alzheimer’s disease remains a
matter of investigation, those who desire to minimize their
exposure can avoid the use of cookware, antacids, baking
powder, or other products that contain aluminum.
7. Include aerobic exercise in your routine, equivalent to 40 mi-
nutes of brisk walking 3 times per week.4. Discussion
The rationale for each of these guidelines is brieﬂy discussed as
follows.
1. Minimize your intake of saturated fats and trans fats.
As reviewed elsewhere in this supplement, several (although
not all) prospective studies have indicated an association between
intake of saturated or trans fats and incident Alzheimer’s disease
(Barnard et al., 2014; Morris, 2014). Saturated fat is found especially
in dairy products and meats; trans fats are found in many snack
foods.
In the Chicago Health and Aging Project, individuals in the
upper quintile of saturated fat intake had twice the risk of
developing Alzheimer’s disease during a 4-year study period,
compared with participants in the lowest quintile (Morris et al.,
2003). In the Washington Heights-Inwood Columbia Aging Proj-
ect in New York and the Cardiovascular Risk Factors, Aging, and
Dementia study in Finland, Alzheimer’s disease risk was posi-
tively, but nonsigniﬁcantly, associated with saturated fat intake
(Laitinen et al., 2006; Luchsinger et al., 2002). A number of well-
controlled studies of cognitive decline have found that high
saturated fat intake increases the rate of decline in cognitive
abilities with age (Beydoun et al., 2007; Devore et al., 2009;
Eskelinen et al., 2008; Heude et al., 2003; Morris et al., 2006b;
Okereke et al., 2012).
Increased saturated fat intake is associated with risk of cardio-
vascular disease and type 2 diabetes (Mahendran et al., 2013; Mann,
2002), which, in turn, are associated with increased risk of Alz-
heimer’sdisease (Oharaet al., 2011;Puglielli et al., 2003).A large study
of Kaiser Permanente patients showed that participants with total
plasma cholesterol levels240mg/dL inmidlife had a 57%higher risk
of Alzheimer’s disease 3 decades later, compared with participants
with cholesterol levels <200 mg/dL (Solomon et al., 2009).
Additional evidence of mechanistic associations between satu-
rated or trans fat intake and Alzheimer’s risk comes from the fact
that the APOEε4 allele, which is strongly linked to Alzheimer’s risk,
produces a protein that plays a key role in cholesterol transport
(Puglielli et al., 2003) and from the observation that high-fat foods
and/or the increases in blood cholesterol concentrations they may
cause may contribute to beta-amyloid production or aggregation in
brain tissues (Puglielli et al., 2001).
2. Vegetables, legumes (beans, peas, and lentils), fruits, and whole
grains should replace meats and dairy products as primary
staples of the diet.
Vegetables, berries, and whole grains provide healthful
micronutrients important to the brain and have little or no satu-
rated fat or trans fats. In both the Chicago Health and Aging Project
and the Nurses’ Health Study cohorts, high vegetable intakes were
associated with reduced cognitive decline (Kang et al., 2005;
Morris et al., 2006a). Legumes and fruits merit emphasis, not
because of an association with reduced Alzheimer’s disease risk,
but because, like grains and vegetables, they provide macronu-
trient nutrition that is essentially free of saturated and trans fats
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cardiovascular disease, weight problems, and type 2 diabetes
(Fraser, 2009; Tonstad et al., 2009), which, in turn, have critical
inﬂuences on brain health.
Many plant-based foods are rich in several B-vitamins. Folate
and vitamin B6 are noteworthy in that, alongwith vitamin B12, they
act as cofactors for the methylation of homocysteine; elevated
homocysteine levels are associated with higher risk of cognitive
impairment in some studies (Morris, 2012; Smith et al., 2010; Vogel
et al., 2009). Nonetheless, the efﬁcacy of B-vitamins is not yet
settled; in an Oxford University study of older individuals with
elevated homocysteine levels and mild cognitive impairment,
supplementation with these 3 vitamins maintained memory per-
formance and reduced the rate of brain atrophy (de Jager et al.,
2012; Douaud et al., 2013; Smith, 2010).
Healthful sources of folate include leafy green vegetables, such
as broccoli, kale, and spinach, beans, peas, citrus fruits, and canta-
loupe. The RDA for folate acid in adults is 400 mg per day. Vitamin B6
is found in green vegetables in addition to beans, whole grains,
bananas, nuts, and sweet potatoes. The RDA for adults up to age 50
is 1.3 mg per day. For adults >50 years older, the RDA is 1.5 mg for
women and 1.7 mg for men.
3. Vitamin E should come from foods, rather than supplements.
Healthful food sources of vitamin E include seeds, nuts, green
leafy vegetables, and whole grains. The RDA for vitamin E is 15
mg per day.
In the Chicago Health and Aging Project, higher intakes of
vitamin E from food sources were associated with reduced Alz-
heimer’s disease incidence (Morris et al., 2005). Similarly, in the
Rotterdam study, high vitamin E intake was associated reduced
dementia incidence (Devore et al., 2010).
Vitamin E occurs naturally in the form of tocopherols and
tocotrienols and is found in many foods, including mangoes, pa-
payas, avocadoes, tomatoes, red bell peppers, and spinach, and
particularly in high quantities in nuts, seeds, and oils. The RDA for
adults is 15mg. A small handful of typical nuts or seeds containsw5
mg of vitamin E.
Vitamin E from supplements has not been shown to reduce
Alzheimer’s disease risk. Many common supplements provide only
a-tocopherol, and most do not replicate the range of vitamin E
forms found in foods. A high intake of a-tocopherol has been shown
to reduce serum concentrations of g- and d-tocopherols (Huang and
Appel, 2003).
4. A Reliable source of vitamin B12, such as fortiﬁed foods or
a supplement providing at least the recommended dietary
allowance (2.4 mg per day for adults) should be part of your
daily diet. Have your blood levels of vitamin B12 checked
regularly as many factors, including age, may impair
absorption.
Vitamin B12 is essential for the health of the brain and nervous
system and for blood cell formation. The RDA for adults is 2.4 mg. It
is found in supplements and fortiﬁed foods, such as some breakfast
cereals or plant milks. Vitamin B12 is also found in meats and dairy
products, although absorption from these sources is limited in
many individuals, particularly those older than 50 years, those with
reduced stomach acid production, those taking certain medications
(e.g., metformin and acid blockers), and individuals who have had
gastrointestinal surgery (e.g., bariatric surgery) or who have Crohn
disease or celiac disease.
The US Government recommends that vitamin B12 from sup-
plements or fortiﬁed foods be consumed by all individuals olderthan 50 years. Individuals on plant-based diets or with absorption
problems should take vitamin B12 supplements regardless of age.
However, dietary sources and even vitamin B12 supplements may
not be sufﬁcient to sustain adequate blood levels. Some individuals
require vitamin B12 injections. Every middle-aged or older adult
should have his or her vitamin B12 status checked on a regular basis.
5. If using multiple vitamins, choose those without iron and
copper and consume iron supplements only when directed by
your physician.
Iron is essential for formation of hemoglobin and certain other
proteins, and copper plays an essential role in enzyme functions
among many other aspects of health. However, some studies have
suggested that excessive iron and copper intake may contribute to
cognitive problems for some individuals (Brewer, 2009; Squitti
et al., 2014; Stankiewicz and Brass, 2009). In recent meta-analyses
(Schrag et al., 2013; Squitti et al., 2013; Ventriglia et al., 2012),
circulating non-protein-bound copper was associated Alzheimer’s
disease risk.
Other aspects of the diet may play a modulating role in the
relationship between metals and cognitive effects. In the Chicago
Health and Aging Project, individuals with a high intake of satu-
rated fat along with a high copper intake were found to have
cognitive decline equivalent to 19 additional years of aging (Morris
et al., 2006b).
Most common multivitamins contain both iron and copper,
sometimes exceeding the RDA (Physicians Committee for
Responsible Medicine, 2013). However, most individuals in the
United States meet the recommended intake of these minerals
from everyday foods and do not require supplementation. The
RDA for iron for women older than 50 years and for men at any age
is 8 mg daily. For women of age 19e50 years, the RDA is 18 mg. The
RDA for copper for men and women is 0.9 mg per day. For in-
dividuals who use multiple vitamins, it is prudent to favor prod-
ucts that deliver vitamins only, unless speciﬁcally directed by
one’s personal physician. Some authorities also suggest speciﬁc
clinical testing (e.g., to measure levels of non-ceruloplasmin
copper) before initiating diet changes (Squitti et al., 2014).
6. Although aluminum’s role in Alzheimer’s disease remains a
matter of investigation, those who desire to minimize their
exposure can avoid the use of cookware, antacids, baking
powder, or other products that contain aluminum.
Aluminum’s role in Alzheimer’s disease remains controversial.
Some researchers have called for caution, citing aluminum’s known
neurotoxic potential when entering the body in more than modest
amounts (Kawahara and Kato-Negishi, 2011) and the fact that
aluminum has been demonstrated in the brains of individuals with
Alzheimer’s disease (Crapper et al., 1973, 1976). Studies in the
United Kingdom and France found increased Alzheimer’s preva-
lence in areas where tap water contained higher aluminum con-
centrations (Martyn et al., 1989; Rondeau et al., 2009). However,
because of the limited number of relevant studies, most experts
regard current evidence as insufﬁcient to indict aluminum as a
contributor to Alzheimer’s disease risk.
Because aluminum plays no role in human biology, it may be
prudent to avoid aluminum exposure to the extent possible,
although its role in cognitive disorders remains under investigation.
Aluminum is found in some brands of baking powder, antacids,
certain food products, and antiperspirants.
7. Include aerobic exercise in your routine, equivalent to 40 mi-
nutes of brisk walking 3 times per week.
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regularly are at reduced risk for Alzheimer’s disease (Erickson et al.,
2012). Adults who exercised in midlife were found to be less likely
to develop dementia after age 65, compared with their sedentary
peers (DeFina et al., 2013). In controlled trials, aerobic exer-
cisedsuch as brisk walking for 40 minutes 3 times per week-
dreduces brain atrophy and improves memory and other cognitive
functions (Hotting and Roder, 2013).
In addition to the foregoing guidelines, other steps merit
further investigation for possible inclusion in future iterations of
prevention guidelines. These could include recommendations as
follows:
1. Maintain a sleep routine that will provide an appropriate
amount of sleep each night, approximately 7e8 hours for most
individuals. It is important to evaluate and treat any underlying
sleep disorders, such as obstructive sleep apnea. Sleep distur-
bances have been associated with cognitive impairment in
older adults (Blackwell, 2011; Lim et al., 2013; Tworoger et al.,
2006; Yaffe et al., 2011).
2. Engage in regular mental activity that promotes new learning,
for example, 30 minutes per day, 4e5 times per week. Several
studies have suggested that individuals who are more mentally
active have reduced risk for cognitive deﬁcits later in life (Curlik
and Shors, 2013; Hotting and Roder, 2013; Robertson, 2013;
Stern, 2012; Tucker and Stern, 2011).5. Conclusions
Although current scientiﬁc evidence is incomplete, substantial
evidence suggests that, a combination of healthful diet steps and
regular physical exercise may reduce the risk of developing Alz-
heimer’s disease. These lifestyle changes present additional bene-
ﬁts, particularly for body weight, cardiovascular health, and
diabetes risk, and essentially no risk of harm. As investigations into
Alzheimer’s disease bear additional fruit, these guidelines should
be modiﬁed accordingly.
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